Prof. András SZÁSZ
St. Istvan University
Professor Andras Szasz was born on 04 November 1947 in Budapest, Hungary. He studied physics at Eotvos University and became department leader in 1985. Later he changed the subject to biophysics and worked at St. Istvan University as head of Biotechnics Department.
He was visiting professor at Strathclyde University, Glasgow, UK; at Pazmany Peter Catholic University, Budapest, Hungary and at Chiba University, Chiba, Japan.
He is Chief Scientific Officer of Oncotherm Hungary and Oncotherm Germany.
The number of his publications is 400+ which includes articles and conference abstracts, he is co-author of eight books and 40+ patents. Professor Szasz is the developer of the method ‘oncothermia’.
Modulated electrohyperthermia (mEHT) for advanced malignant tumors
mEHT is a selective heating method, targeting the malignant cells and inducing apoptosis for their elimination from the body. The method forms DAMP and induces ICD, making the forming of tumour-specific immune reactions creating abscopal effect possible all over the human body. The method is applicable for all primary or metastatic malignant tumours, also in relapsed or refractory situations. It simultaneously increases the survival time with the quality of life.
EVEN MORE SEMINARS
Professor Robert Thomas Bedford and Addenbrooke's Cambridge University Hospitals
Evidence based lifestyle strategies after cancer - a research review
Malcolm Wilson The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester
Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours
Chris Carrigan Bowel Cancer Intelligence UK
Patient Engagement in the uses of Patient Data
Geeta Shetty, MBBS, MS(Gen.Surg), DNB(Gen.Surg), DM, FRCS(Gen.Surg) Sandwell and West Birmingham Hospitals NHS Trust
Chest Wall Perforator Flaps for Partial Breast Reconstruction
Dr Shanmugasundaram Ramkumar University Hospital Southampton NHS Foundation Trust
Radiotherapy developments in management of recurrent rectal cancers